Commentary

Clinical practice guidelines (‘guidelines’) are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.1 The Scottish Dental Clinical Effectiveness Programme (SCDEP) http://www.sdcep.org.uk was established in 2004 to provide guidance for the dental profession. For each clinical guideline, a guideline development group (GDG) assesses the best available evidence and reaches consensus to provide clinical recommendations. Their most recent guidance document relates to the prevention and treatment of periodontal diseases (primarily chronic periodontitis) in a primary dental care setting.

This guidance document has several components. The majority of the document is like a textbook in that it provides clear, step-by-step strategies for assessment and diagnosis – both clinical and radiographic, changing patient behavior (ie oral hygiene, smoking cessation), non-surgical therapy, maintenance of periodontal and implant health, policies for referral to specialty care and record keeping. It is designed to be used by general dentists, hygienists and therapists and would be particularly useful for education of dental clinicians. It is thorough and thoughtfully prepared. The assessment section includes recommendations for screening using the Basic Periodontal Examination (BPE – also known in North America as Periodontal Screening and Recording), when it is appropriate to take radiographs and which type to take, and a useful algorithm for assigning risk levels for development of periodontal diseases.

For development of the guidance document, the GDG formulated 20 key clinical questions. A systematic search of seven databases was conducted to identify the best available research up to October 2013. While periodontics is one area in oral health in which a significant amount of primary research and systematic reviews have been conducted, the evidence is not always strong, and the systematic reviews not always rigorously carried out. Nonetheless, the GDG evaluated the available evidence and developed clinical recommendations for each of the questions. When authoritative evidence was not available, the GDG made recommendations based on current best practice (presumably based on advice from experts). These recommendations are clearly identified in the ‘Evidence into Practice’ section. (Of course, there is also the ubiquitous ‘Recommendations for Future Research’ found in any guideline – which, it seems, no researcher ever actually follows).

One of the key messages in the guidance document is that management of periodontal health is a partnership between patient and clinician and requires a life-long commitment. Engaging patients in decision-making and therapy – through behavioural modification – is the key to success. To that end, a video of the implementation of TIPPS (Teach, Instruct, Practise, Plan and Support) is available from their website. Other tools for implementation include advice for medical practitioners and patient leaflets, including one for people with diabetes.

The potential benefit of any guideline is only as good as the quality of the guideline itself. This guidance document meets the requirements set out by the AGREE document2 in that the appropriate stakeholders were involved in its development, there are clear links between the evidence and the recommendations, the scope of the guideline and key recommendations are clear and specific, and additional tools are provided to facilitate application of the recommendations. Guidelines are not meant to replace clinical judgment. Nonetheless, this document provides excellent support for decision making between clinicians and their patients.

Practice point

While there are 20 key recommendations for the assessment and treatment of periodontal diseases in primary care, these have been summarised below.

In patients diagnosed with chronic periodontitis

  • The most important factor for success is the patient's own plaque control, and that this is best achieved through engaging the patient and applying principles of behavior modification (TIPPS)

  • Daily, effective plaque removal using a manual or rechargeable oscillating toothbrush and floss and/or interdental brush is recommended to maintain periodontal and peri-implant health.

In sites around teeth and implants demonstrating inflammation (ie probing depths ≥4 mm with sub-gingival deposits and/or which bleed on probing)

  • Supra-gingival debridement and sub-gingival root surface instrumentation (using hand or power driven instruments; in one or more sessions) is the most appropriate treatment

  • The addition of chemotherapeutics (local or systemic antimicrobials or host modulating therapies) provides no additional clinical benefit to mechanical debridement.

Following active therapy

  • The length between recall appointments and the need for referral for specialty care should be individualised for each patient by assessing their periodontal status and risk for ongoing attachment loss at each recall visit.